We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Inyx, Inc., a specialty pharmaceutical company focused on niche drug delivery technologies and products, announced today that its wholly owned U.K. subsidiary, Ashton Pharmaceuticals Ltd., has been selected by a leading Indian specialty pharmaceutical company to manufacture a range of generic drugs for the United Kingdom and other European countries.
Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) a bio-pharmaceutical company, announced today that effective June 27, 2006, the company has received US patent approval for treatment of rheumatoid arthritis by administering Product R (AVR118), a peptide-nucleic acid preparation.
Technologies Inc., maker of COLD-fXTM, today announced that it has reached an agreement to begin construction of a facility to house its corporate headquarters and research and development activities.
Novartis announced that it has acquired or received valid acceptances for 75.4 per cent of the outstanding shares in NeuTec Pharma plc and has declared its offer for the UK biopharmaceutical company unconditional in all respects.
Sen. Richard Burr (R-N.C.) was expected July 17 to introduce his long-awaited biodefense bill after removing provisions that were opposed by HHS and activists, congressional sources said.